Newsletter & E-Newsletter, Vol. 40(6) is now available.
The web version is available here.
( Click here to see the list of Newsletters )
This issue,
- Topics “Pharmacokinetic Society of Japan Newsletter: Regulatory Science Information“
- NEW POWER for pharmacokinetic research ““Seeing the Invisible”, a view seen through pharmacokinetic research” Bio-DMPK and Systems Pharmacology Group, Pharmacokinetics and Safety Research Department, Ono Pharmaceutical Co. Seitaro Otsu
- Pharmacokinetics of Engineered Antibodies “Part 2: FcRn binding enhanced engineered antibodies” DMPKG, Discovery Biologics Department, Research Division, Chugai Pharmaceutical Co., LTD. Shunsuke Yamada, Kenta Haraya
- Comments from the Award Winner
- “On receiving the Drug Discovery Contribution and Encouragement Award” Miho Nagayasu, Translational Research Division, Chugai Pharmaceutical Co.
- “On receiving the Drug Discovery Contribution and Encouragement Award” Miyu Nakayama, Takeda Pharmaceutical Company Limited Pharmacokinetics Research Laboratories
- “On receiving the Encouragement Award” Hidefumi Mukai, Nagasaki University Graduate School of Biomedical Sciences (Pharmaceutical Sciences)
- “On receiving the Drug Discovery Contribution and Kitagawa Award” Hideki Hirabayashi, CTO/CRO Business Division, TN Technos, Inc.
- List of papers to be published in DMPK 65
The contents of this newsletter are substantial, including the following.
If you are not a member yet, please consider joining. ( Click here for membership information.)
The newsletter is sent to all members and web members, and can also be viewed here. Even if you are not yet a member of the Japanese Pharmacokinetics Society, you can receive the newsletter by simply registering your e-mail address as a Web member.